The IL-17 signaling pathway has been shown to be effective in the treatment of colorectal cancer [55], breast cancer [56], gastric cancer [57], prostate cancer [58], and laryngeal squamous cell carcinoma [59]. Here, IL17A is linked to Familial prostate cancer.